ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

BPK Bespak

667.00
0.00 (0.00%)
26 Apr 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Bespak LSE:BPK London Ordinary Share GB0000946276 ORD 10P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 667.00 - 0.00 01:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
0 0 N/A 0

Bespak Share Discussion Threads

Showing 1 to 5 of 150 messages
Chat Pages: 6  5  4  3  2  1
DateSubjectAuthorDiscuss
05/11/2002
08:24
BPK - 3 main reasons these should continue to have problems:

1. Weston Medical syringe delays...nuff said on that thread already.
2. Inhale Therapeutics - inhaled insulin - which quite frankly, will be years before its accepted by the medical establishment as dosing depends on patients lung tissue and health - not an issue with injected dosing.
3 - this is the biggy - delays with CFC devices in the US. There is much anecdotal evidence that prevalence of asthma is plateauing as the general health of the Western world improves - customers have over-ordered and quite clearly are having difficulty shifting stock.

Also - with the pressure on the pharma industry in general to cut costs, the development of new fancy inhaler devices will be questioned closely.

For some reason there now seems to be a lot of emphasis on nasal drug delivery for this company. This is an even more unpredicatable way to deliver drugs with such a variable dose absorption depending on the state of people's nasal mucosa. They should have stuck to the knitting.

cat
18/7/2002
13:17
Check out NWD for a quick profit. MMs obviously short of stock, worth buying a few for a quick 20% gain.
market_leader 2002
06/4/2002
12:33
* Medical devices company Bespak’s (BPK) non-executive director William Meredith has been shopping on the other side of the Atlantic as he picked up 5,000 American Depository Receipts on Wednesday at $7.50 (523p). His £26,130 payout doubles his holding in the company to 10,000 ADRs.

Meredith has pounced while Bespak’s share price is struggling close to its year-low. It began the year in sprightly fashion at a high of 590p but fell gradually until it hit 500p last week. After a brief rally it has stalled and today closed down 1p at 504p.

In January the company reported record sales in the six months to 2 November of £42.9 million, up from £40.4 million the previous year. However pre-tax profits slipped from £7.8 million to £7.2 million after higher research and development costs.

daycase1
28/2/2002
11:25
well i dont follow but i do have cash invested ( £1.20 )
cleverboy
13/11/2001
01:54
Anyone follow this dog?
sham3001
Chat Pages: 6  5  4  3  2  1

Your Recent History

Delayed Upgrade Clock